Clinical Significance of Bacillus Species other than Bacillus anthracis: A Case Series With Review of Literature

Technical Summary: Clinical Significance of Bacillus Species Other Than Bacillus anthracis

Problem Statement
Bacillus species (spp.), excluding the obligate pathogen Bacillus anthracis, are frequently dismissed by clinicians and laboratory personnel as mere contaminants in clinical cultures. They are often reported simply as "aerobic spore-forming bacilli" (ASB) without further investigation. However, growing evidence suggests that non-anthracis Bacillus spp. (such as B. cereus, B. subtilis, and B. licheniformis) act as opportunistic pathogens, particularly in immunocompromised individuals, neonates, and hospitalized patients. The clinical challenge lies in distinguishing true bacteremia and sepsis caused by these organisms from incidental environmental contamination, a misclassification that can lead to either the neglect of a serious infection or the unnecessary administration of broad-spectrum antibiotics.

Methodology
This study is a retrospective case series conducted at a tertiary care teaching hospital in Karimnagar, Telangana, India, covering the period from April 2018 to March 2019.

• Study Population: Seven patients were included who presented with clinical signs of sepsis and had blood cultures yielding pure growth of Gram-positive bacilli identified as Bacillus spp. The cohort consisted of five neonates, one young adult with Type 1 Diabetes Mellitus (T1DM), and one elderly postoperative patient.
• Data Collection: Comprehensive clinical data were extracted, including demographics, maternal/perinatal history (for neonates), comorbidities, presenting symptoms, laboratory parameters (hematology, coagulation, inflammatory markers like CRP), and treatment outcomes.
• Microbiological Analysis: Isolates were identified using standard phenotypic methods (colony morphology, Gram stain, motility, catalase, nitrate reduction, and starch hydrolysis). Antimicrobial Susceptibility Testing (AST) was performed via the Kirby-Bauer disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines against a broad panel of antibiotics.
• Exclusion Criteria: Cases with Bacillus growth lacking clinical correlation or with inadequate medical records were excluded.

Key Contributions
The paper provides a detailed clinical profile of seven confirmed cases of Bacillus spp. bacteremia, emphasizing the spectrum of disease across different age groups.

1. Neonatal Vulnerability: The study highlights that neonates, particularly those who are premature or low birth weight, are a high-risk group. Five of the seven cases were neonates, all presenting with respiratory distress and sepsis.
2. Adult Pathogenicity: The series documents significant infections in non-neonatal populations, specifically a young adult with T1DM and a chronic foot ulcer, and an elderly patient following abdominal surgery, reinforcing that Bacillus spp. are not limited to neonatal sepsis.
3. Antimicrobial Resistance Profiles: The paper details specific resistance patterns observed in the isolates, noting that while susceptibility to vancomycin and meropenem was consistent, resistance to other agents (e.g., penicillin, certain cephalosporins, macrolides) varied, underscoring the necessity of AST.
4. Diagnostic Framework: The authors propose a framework for clinical correlation, suggesting that elevated inflammatory markers (specifically CRP) and clinical signs of sepsis should trigger the consideration of Bacillus spp. as a true pathogen rather than a contaminant.

Results

• Demographics and Risk Factors: Of the 7 patients, 5 (71.4%) were neonates. Major risk factors in the neonatal group included prematurity (60%), low birth weight (80%), maternal anemia (40%), prolonged rupture of membranes, and meconium aspiration. The adult cases involved significant comorbidities: T1DM with a trophic ulcer and advanced age with recent major surgery.
• Clinical Presentation: Neonates predominantly presented with respiratory distress (100%), hyperbilirubinemia (60%), thrombocytopenia (40%), and coagulopathy (40%). The adult patients presented with sepsis, seizures (in the diabetic patient), and abdominal pain (in the postoperative patient).
• Microbiological Findings: All isolates were confirmed as Bacillus spp. via standard biochemical testing.
  • Susceptibility: All isolates were susceptible to piperacillin-tazobactam, amikacin, meropenem, and vancomycin.
  • Resistance: Specific resistance patterns were noted. The adult diabetic patient's isolate was resistant to clindamycin, azithromycin, erythromycin, cefotaxime, and ceftazidime. The elderly postoperative patient's isolate showed resistance to ceftazidime, oxacillin, erythromycin, clindamycin, and penicillin.
• Outcomes: Prompt targeted antimicrobial therapy and supportive care resulted in favorable outcomes for 6 out of 7 patients (85.7%). There was no neonatal mortality. The single unfavorable outcome involved the elderly patient who left against medical advice (LAMA) shortly after treatment initiation.

Significance and Claims
The authors assert that Bacillus spp. (other than B. anthracis) are clinically significant opportunistic pathogens capable of causing bacteremia and sepsis across diverse age groups, not just in neonates. The paper claims that these organisms should not be reflexively dismissed as contaminants.

The significance of the findings rests on three main points:

1. Clinical Correlation is Vital: Differentiation between contamination and true infection requires careful correlation with clinical features (e.g., respiratory distress, fever) and inflammatory markers (e.g., elevated CRP).
2. Importance of AST: Empirical therapy may be insufficient due to variable resistance patterns; therefore, antimicrobial susceptibility testing is essential to guide effective treatment, particularly in immunocompromised hosts.
3. Outcome Dependency: Early recognition and targeted therapy are critical. The study notes that delayed treatment in neonatal Bacillus sepsis can lead to high mortality rates (citing literature suggesting 30–50% in outbreaks), whereas prompt management in this series led to recovery in all neonatal cases.

The authors conclude that while Bacillus carriage may be transient and environmentally acquired, the potential for invasive disease in vulnerable populations necessitates a shift in clinical attitude from dismissal to active investigation and management.